These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 19497432)

  • 1. Microarray analysis of gene expression in gynecologic cancers--still only the beginning.
    Berchuck A
    Gynecol Oncol; 2009 Jul; 114(1):1-2. PubMed ID: 19497432
    [No Abstract]   [Full Text] [Related]  

  • 2. Ploidy in gynaecological cancers.
    Fox H
    Histopathology; 2005 Feb; 46(2):121-9. PubMed ID: 15693883
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the relations between blood groups of the ABO system and neoplasms of the female genital system. I. Ovarian carcinoma].
    Cozzi M; Gualandri V
    Minerva Ginecol; 1967 Oct; 19(19):968-72. PubMed ID: 5609934
    [No Abstract]   [Full Text] [Related]  

  • 4. [Gynecologic cancers--the limits of preventive examination. An analysis of the current staging and percentage distributions based on 3,849 cancers from the 1 January 1983 to 25 November 1985 cumulative statistics of the study group of Swiss gynecologic clinics].
    Hochuli E; Benz J; Litschgi M; Marti WK
    Schweiz Rundsch Med Prax; 1986 Jun; 75(26):792-8. PubMed ID: 3489265
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular biology of gynecologic malignancies.
    Hamilton TC; Johnson SW; Godwin AK
    Cancer Treat Res; 1998; 95():103-14. PubMed ID: 9619281
    [No Abstract]   [Full Text] [Related]  

  • 6. [Research on molecular genetics in gynecologic tumor: development and regulation].
    Wang Y
    Zhonghua Fu Chan Ke Za Zhi; 1996 Nov; 31(11):643-5. PubMed ID: 9387520
    [No Abstract]   [Full Text] [Related]  

  • 7. Carcinosarcoma of the ovary a review.
    Cantrell LA; Van Le L
    Obstet Gynecol Surv; 2009 Oct; 64(10):673-80; quiz 697. PubMed ID: 19772676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological significance of DEK overexpression in serous ovarian tumors.
    Han S; Xuan Y; Liu S; Zhang M; Jin D; Jin R; Lin Z
    Pathol Int; 2009 Jul; 59(7):443-7. PubMed ID: 19563407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel lymph node biopsy in the management of vulvar carcinoma, cervical cancer, and endometrial cancer.
    Zivanovic O; Khoury-Collado F; Abu-Rustum NR; Gemignani ML
    Oncologist; 2009 Jul; 14(7):695-705. PubMed ID: 19608640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.
    Gorringe KL; Ramakrishna M; Williams LH; Sridhar A; Boyle SE; Bearfoot JL; Li J; Anglesio MS; Campbell IG
    Genes Chromosomes Cancer; 2009 Oct; 48(10):931-42. PubMed ID: 19603523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-Dimensional microarray analysis of estrogen signal-related genes in breast cancer tissues.
    Matsumoto M; Sakamoto H; Yamaguchi Y; Seino Y; Takei H; Kurosumi M; Sasano H; Yaegashi N; Hayashi S
    Anticancer Res; 2009 Oct; 29(10):3971-5. PubMed ID: 19846938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visualization of regional gene expression biases by microarray data sorting.
    van Eijk R; Oosting J; Sieben N; van Wezel T; Cleton-Jansen AM
    Biotechniques; 2004 Apr; 36(4):592-4, 596. PubMed ID: 15088376
    [No Abstract]   [Full Text] [Related]  

  • 13. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
    Zhang Y; Wang J; Xiang D; Wang D; Xin X
    Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. eEF1A2 as a putative oncogene.
    Lee MH; Surh YJ
    Ann N Y Acad Sci; 2009 Aug; 1171():87-93. PubMed ID: 19723040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hereditary gynecologic cancer: the pathologist's point of view].
    Sabourin JC
    Ann Pathol; 2010 Nov; 30(5 Suppl 1):88-9. PubMed ID: 21055556
    [No Abstract]   [Full Text] [Related]  

  • 16. Association between the N-terminally truncated (DeltaN) p63alpha (DeltaNp63alpha) isoform and debulking status, VEGF expression and progression-free survival in previously untreated, advanced stage epithelial ovarian cancer: A Gynecologic Oncology Group study.
    Jewell EL; Darcy KM; Hutson A; Lee PS; Havrilesky LJ; Grace LA; Berchuck A; Secord AA
    Gynecol Oncol; 2009 Dec; 115(3):424-9. PubMed ID: 19767063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cooperative researches for gynecologic cancers in Japan].
    Takakura S; Ochiai K
    Nihon Rinsho; 2012 Jun; 70 Suppl 4():52-8. PubMed ID: 23156217
    [No Abstract]   [Full Text] [Related]  

  • 18. Microarray based analysis of microRNA expression in rat cerebral cortex after traumatic brain injury.
    Lei P; Li Y; Chen X; Yang S; Zhang J
    Brain Res; 2009 Aug; 1284():191-201. PubMed ID: 19501075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laparoscopy and gynecologic oncology.
    Cho JE; Liu C; Gossner G; Nezhat FR
    Clin Obstet Gynecol; 2009 Sep; 52(3):313-26. PubMed ID: 19661747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [DNA and microRNA microarray technologies in diagnostics and prediction for patients with renal cell carcinoma].
    Slabý O; Svoboda M; Michálek J; Vyzula R
    Klin Onkol; 2009; 22(5):202-9. PubMed ID: 19886357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.